Neonatal pulmonary hypertension

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

When the normal cardiopulmonary transition fails to occur, the result is persistent pulmonary hypertension of the newborn. Severe persistent pulmonary hypertension of the newborn is estimated to occur in 2 per 1000 live-born term infants, and some degree of pulmonary hypertension complicates the course of >10% of all neonates with respiratory failure. This review article discusses the vascular abnormalities that are associated with neonatal pulmonary hypertension, including recognition of its role in severe bronchopulmonary dysplasia in preterm infants. A systematic review of the evidence for common therapies including inhaled nitric oxide, high-frequency ventilation, surfactant, and extracorporeal life support is included. Finally, this field is rapidly evolving, and the rationale for promising new treatment approaches is reviewed, including inhibition of phosphodiesterases and scavengers of reactive oxygen species. (Pediatr Crit Care Med 2010; 11[Suppl.]:S79 -S84).

Original languageEnglish (US)
JournalPediatric Critical Care Medicine
Volume11
Issue numberSUPPL. 2
DOIs
StatePublished - Mar 2010
Externally publishedYes

Fingerprint

Persistent Fetal Circulation Syndrome
Pulmonary Hypertension
High-Frequency Ventilation
Bronchopulmonary Dysplasia
Extracorporeal Membrane Oxygenation
Phosphoric Diester Hydrolases
Premature Infants
Surface-Active Agents
Respiratory Insufficiency
Blood Vessels
Reactive Oxygen Species
Nitric Oxide
Newborn Infant
Therapeutics

Keywords

  • High-frequency ventilation
  • Nitric oxide
  • Oxygen
  • Phosphodiesterase reactive oxygen species

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care and Intensive Care Medicine

Cite this

Neonatal pulmonary hypertension. / Steinhorn, Robin H.

In: Pediatric Critical Care Medicine, Vol. 11, No. SUPPL. 2, 03.2010.

Research output: Contribution to journalArticle

@article{b6dd97bd3c864b03a7f9fe2463ca0780,
title = "Neonatal pulmonary hypertension",
abstract = "When the normal cardiopulmonary transition fails to occur, the result is persistent pulmonary hypertension of the newborn. Severe persistent pulmonary hypertension of the newborn is estimated to occur in 2 per 1000 live-born term infants, and some degree of pulmonary hypertension complicates the course of >10{\%} of all neonates with respiratory failure. This review article discusses the vascular abnormalities that are associated with neonatal pulmonary hypertension, including recognition of its role in severe bronchopulmonary dysplasia in preterm infants. A systematic review of the evidence for common therapies including inhaled nitric oxide, high-frequency ventilation, surfactant, and extracorporeal life support is included. Finally, this field is rapidly evolving, and the rationale for promising new treatment approaches is reviewed, including inhibition of phosphodiesterases and scavengers of reactive oxygen species. (Pediatr Crit Care Med 2010; 11[Suppl.]:S79 -S84).",
keywords = "High-frequency ventilation, Nitric oxide, Oxygen, Phosphodiesterase reactive oxygen species",
author = "Steinhorn, {Robin H}",
year = "2010",
month = "3",
doi = "10.1097/PCC.0b013e3181c76cdc",
language = "English (US)",
volume = "11",
journal = "Pediatric Critical Care Medicine",
issn = "1529-7535",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Neonatal pulmonary hypertension

AU - Steinhorn, Robin H

PY - 2010/3

Y1 - 2010/3

N2 - When the normal cardiopulmonary transition fails to occur, the result is persistent pulmonary hypertension of the newborn. Severe persistent pulmonary hypertension of the newborn is estimated to occur in 2 per 1000 live-born term infants, and some degree of pulmonary hypertension complicates the course of >10% of all neonates with respiratory failure. This review article discusses the vascular abnormalities that are associated with neonatal pulmonary hypertension, including recognition of its role in severe bronchopulmonary dysplasia in preterm infants. A systematic review of the evidence for common therapies including inhaled nitric oxide, high-frequency ventilation, surfactant, and extracorporeal life support is included. Finally, this field is rapidly evolving, and the rationale for promising new treatment approaches is reviewed, including inhibition of phosphodiesterases and scavengers of reactive oxygen species. (Pediatr Crit Care Med 2010; 11[Suppl.]:S79 -S84).

AB - When the normal cardiopulmonary transition fails to occur, the result is persistent pulmonary hypertension of the newborn. Severe persistent pulmonary hypertension of the newborn is estimated to occur in 2 per 1000 live-born term infants, and some degree of pulmonary hypertension complicates the course of >10% of all neonates with respiratory failure. This review article discusses the vascular abnormalities that are associated with neonatal pulmonary hypertension, including recognition of its role in severe bronchopulmonary dysplasia in preterm infants. A systematic review of the evidence for common therapies including inhaled nitric oxide, high-frequency ventilation, surfactant, and extracorporeal life support is included. Finally, this field is rapidly evolving, and the rationale for promising new treatment approaches is reviewed, including inhibition of phosphodiesterases and scavengers of reactive oxygen species. (Pediatr Crit Care Med 2010; 11[Suppl.]:S79 -S84).

KW - High-frequency ventilation

KW - Nitric oxide

KW - Oxygen

KW - Phosphodiesterase reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=77949471213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949471213&partnerID=8YFLogxK

U2 - 10.1097/PCC.0b013e3181c76cdc

DO - 10.1097/PCC.0b013e3181c76cdc

M3 - Article

VL - 11

JO - Pediatric Critical Care Medicine

JF - Pediatric Critical Care Medicine

SN - 1529-7535

IS - SUPPL. 2

ER -